Clinicopathological Analysis of 14 Cases of Primary Pulmonary Lymphoepithelial Carcinoma

Background and objective Primary pulmonary lymphoepithelial carcinoma (PPLEC) is a rare form of lung malignancy, accounting for only 0.7% of all lung cancers. It is currently classified as a distinct subtype within squamous cell carcinomas. This study aims to explore the clinicopathological characte...

Full description

Saved in:
Bibliographic Details
Main Authors: Yixuan FANG, Anzhe WANG, Lumin SHEN, Xiao YUAN, Yu KONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2024-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2024.101.29
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544081407213568
author Yixuan FANG
Anzhe WANG
Lumin SHEN
Xiao YUAN
Yu KONG
author_facet Yixuan FANG
Anzhe WANG
Lumin SHEN
Xiao YUAN
Yu KONG
author_sort Yixuan FANG
collection DOAJ
description Background and objective Primary pulmonary lymphoepithelial carcinoma (PPLEC) is a rare form of lung malignancy, accounting for only 0.7% of all lung cancers. It is currently classified as a distinct subtype within squamous cell carcinomas. This study aims to explore the clinicopathological characteristics of PPLEC and its subtypes, with the objective of enhancing understanding and improving diagnostic accuracy for this disease. Methods A retrospective analysis was conducted on the clinical, pathological, imaging, and prognostic data of 14 patients diagnosed with PPLEC at the First Affiliated Hospital of Soochow University between February 2019 and June 2023. Results A total of 14 cases of PPLEC were identified, including 5 cases of the Regaud type, with ages ranging from 33 to 73 years, comprising 2 males and 3 females; and 9 cases of the Schmincke type, with ages ranging from 36 to 79 years, including 4 males and 5 females. Computed tomography (CT) scans consistently demonstrated soft tissue masses or nodular shadows. Reagud type mainly showed peripheral masses and Schmincke type mainly showed central masses. Pathological examination revealed tumor cells exhibiting syncytial-like growth, accompanied by lymphocytic infiltration and stromal fibrosis, with the Regaud type showing well-defined borders combined with granulomatous inflammation, while the Schmincke type exhibited indistinct tumor margins. Immunohistochemistry showed that CK, CK5/6, P40 and P63 were positive, and the Ki-67 index of Regaud type was lower than that of Schmincke type; notably, all 8 cases tested for programmed death-ligand 1 (PD-L1) were positive. Epstein-Barr virus-encoded RNA (EBER) in situ hybridization was positive in all instances. Among these cases, 6 underwent surgical treatment, and 8 received comprehensive therapy; by the end of the follow-up period, all 14 patients remained alive. Conclusion PPLEC is a rare form of malignant lung tumor associated with Epstein-Barr virus (EBV) infection. The Regaud and Schmincke subtypes display distinct imaging and pathological characteristics. In the early stages of the disease, surgical intervention is the primary treatment method; however, for advanced stages, a multimodal treatment approach is utilized, resulting in a relatively favorable prognosis. Immunotherapy represents a promising and effective treatment modality for patients with middle to advanced stage disease exhibiting high PD-L1 expression levels.
format Article
id doaj-art-6e7fb581f3c54d2a90d707914bbe91c3
institution Kabale University
issn 1009-3419
1999-6187
language zho
publishDate 2024-11-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj-art-6e7fb581f3c54d2a90d707914bbe91c32025-01-13T02:46:02ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872024-11-01271184084810.3779/j.issn.1009-3419.2024.101.29Clinicopathological Analysis of 14 Cases of Primary Pulmonary Lymphoepithelial CarcinomaYixuan FANG0Anzhe WANG1Lumin SHEN2Xiao YUAN3Yu KONG4Department of Pathology, the First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaDepartment of Pathology, the First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaDepartment of Pathology, the First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaDepartment of Pathology, the First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaDepartment of Pathology, the First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaBackground and objective Primary pulmonary lymphoepithelial carcinoma (PPLEC) is a rare form of lung malignancy, accounting for only 0.7% of all lung cancers. It is currently classified as a distinct subtype within squamous cell carcinomas. This study aims to explore the clinicopathological characteristics of PPLEC and its subtypes, with the objective of enhancing understanding and improving diagnostic accuracy for this disease. Methods A retrospective analysis was conducted on the clinical, pathological, imaging, and prognostic data of 14 patients diagnosed with PPLEC at the First Affiliated Hospital of Soochow University between February 2019 and June 2023. Results A total of 14 cases of PPLEC were identified, including 5 cases of the Regaud type, with ages ranging from 33 to 73 years, comprising 2 males and 3 females; and 9 cases of the Schmincke type, with ages ranging from 36 to 79 years, including 4 males and 5 females. Computed tomography (CT) scans consistently demonstrated soft tissue masses or nodular shadows. Reagud type mainly showed peripheral masses and Schmincke type mainly showed central masses. Pathological examination revealed tumor cells exhibiting syncytial-like growth, accompanied by lymphocytic infiltration and stromal fibrosis, with the Regaud type showing well-defined borders combined with granulomatous inflammation, while the Schmincke type exhibited indistinct tumor margins. Immunohistochemistry showed that CK, CK5/6, P40 and P63 were positive, and the Ki-67 index of Regaud type was lower than that of Schmincke type; notably, all 8 cases tested for programmed death-ligand 1 (PD-L1) were positive. Epstein-Barr virus-encoded RNA (EBER) in situ hybridization was positive in all instances. Among these cases, 6 underwent surgical treatment, and 8 received comprehensive therapy; by the end of the follow-up period, all 14 patients remained alive. Conclusion PPLEC is a rare form of malignant lung tumor associated with Epstein-Barr virus (EBV) infection. The Regaud and Schmincke subtypes display distinct imaging and pathological characteristics. In the early stages of the disease, surgical intervention is the primary treatment method; however, for advanced stages, a multimodal treatment approach is utilized, resulting in a relatively favorable prognosis. Immunotherapy represents a promising and effective treatment modality for patients with middle to advanced stage disease exhibiting high PD-L1 expression levels.http://dx.doi.org/10.3779/j.issn.1009-3419.2024.101.29primary pulmonary lymphoepithelial carcinomasubtypeprognosis
spellingShingle Yixuan FANG
Anzhe WANG
Lumin SHEN
Xiao YUAN
Yu KONG
Clinicopathological Analysis of 14 Cases of Primary Pulmonary Lymphoepithelial Carcinoma
Chinese Journal of Lung Cancer
primary pulmonary lymphoepithelial carcinoma
subtype
prognosis
title Clinicopathological Analysis of 14 Cases of Primary Pulmonary Lymphoepithelial Carcinoma
title_full Clinicopathological Analysis of 14 Cases of Primary Pulmonary Lymphoepithelial Carcinoma
title_fullStr Clinicopathological Analysis of 14 Cases of Primary Pulmonary Lymphoepithelial Carcinoma
title_full_unstemmed Clinicopathological Analysis of 14 Cases of Primary Pulmonary Lymphoepithelial Carcinoma
title_short Clinicopathological Analysis of 14 Cases of Primary Pulmonary Lymphoepithelial Carcinoma
title_sort clinicopathological analysis of 14 cases of primary pulmonary lymphoepithelial carcinoma
topic primary pulmonary lymphoepithelial carcinoma
subtype
prognosis
url http://dx.doi.org/10.3779/j.issn.1009-3419.2024.101.29
work_keys_str_mv AT yixuanfang clinicopathologicalanalysisof14casesofprimarypulmonarylymphoepithelialcarcinoma
AT anzhewang clinicopathologicalanalysisof14casesofprimarypulmonarylymphoepithelialcarcinoma
AT luminshen clinicopathologicalanalysisof14casesofprimarypulmonarylymphoepithelialcarcinoma
AT xiaoyuan clinicopathologicalanalysisof14casesofprimarypulmonarylymphoepithelialcarcinoma
AT yukong clinicopathologicalanalysisof14casesofprimarypulmonarylymphoepithelialcarcinoma